BR112018076875A2 - método de pré-ativação de um sistema imune de sus. - Google Patents

método de pré-ativação de um sistema imune de sus.

Info

Publication number
BR112018076875A2
BR112018076875A2 BR112018076875-8A BR112018076875A BR112018076875A2 BR 112018076875 A2 BR112018076875 A2 BR 112018076875A2 BR 112018076875 A BR112018076875 A BR 112018076875A BR 112018076875 A2 BR112018076875 A2 BR 112018076875A2
Authority
BR
Brazil
Prior art keywords
sus
immune system
activation method
activation
birth
Prior art date
Application number
BR112018076875-8A
Other languages
English (en)
Inventor
Gilbertie Aaron
Berger Steven
Zuckerman Federico
Original Assignee
Aptimmune Biologics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aptimmune Biologics, Inc. filed Critical Aptimmune Biologics, Inc.
Publication of BR112018076875A2 publication Critical patent/BR112018076875A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/02—Breeding vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

são revelados métodos de pré-ativação de um sistema imune de sus. os métodos compreendem administrar uma quantidade eficaz de um lisado celular completo micobacteriano a um sus dentro de um período de tempo eficaz após o nascimento do sus.
BR112018076875-8A 2016-06-24 2017-06-23 método de pré-ativação de um sistema imune de sus. BR112018076875A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662354534P 2016-06-24 2016-06-24
US62/354534 2016-06-24
PCT/US2017/039110 WO2017223510A1 (en) 2016-06-24 2017-06-23 Methods of priming a sus' immune system

Publications (1)

Publication Number Publication Date
BR112018076875A2 true BR112018076875A2 (pt) 2019-04-02

Family

ID=60783269

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018076875-8A BR112018076875A2 (pt) 2016-06-24 2017-06-23 método de pré-ativação de um sistema imune de sus.

Country Status (13)

Country Link
US (1) US20190374631A1 (pt)
EP (1) EP3478317A4 (pt)
JP (1) JP2019522659A (pt)
KR (1) KR20190020805A (pt)
CN (1) CN109562155A (pt)
BR (1) BR112018076875A2 (pt)
CA (1) CA3028437A1 (pt)
GB (1) GB2566879A (pt)
MX (1) MX2018015537A (pt)
PH (1) PH12018502675A1 (pt)
RU (1) RU2019101814A (pt)
TW (1) TW201806609A (pt)
WO (1) WO2017223510A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1549135A4 (en) * 2002-09-20 2006-01-11 Us Agriculture VACCINE AND ADJUVANT COMPOSITIONS
WO2006076343A1 (en) * 2005-01-12 2006-07-20 Albert Einstein College Of Medicine Of Yeshiva University Mycobacteria expressing hiv-1 and malaria antigens
CN1318573C (zh) * 2005-06-13 2007-05-30 中国药品生物制品检定所 耻垢分枝杆菌制剂及其应用
GB0526033D0 (en) * 2005-12-21 2006-02-01 Bioeos Ltd Method
CN104797269A (zh) * 2012-04-24 2015-07-22 俄亥俄州国家创新基金会 用于治疗和预防猪繁殖与呼吸综合征的组合物和方法

Also Published As

Publication number Publication date
EP3478317A1 (en) 2019-05-08
CN109562155A (zh) 2019-04-02
GB2566879A (en) 2019-03-27
KR20190020805A (ko) 2019-03-04
CA3028437A1 (en) 2017-12-28
GB201900899D0 (en) 2019-03-13
MX2018015537A (es) 2019-09-16
PH12018502675A1 (en) 2019-10-21
WO2017223510A1 (en) 2017-12-28
EP3478317A4 (en) 2020-03-04
US20190374631A1 (en) 2019-12-12
RU2019101814A (ru) 2020-07-27
JP2019522659A (ja) 2019-08-15
TW201806609A (zh) 2018-03-01
RU2019101814A3 (pt) 2020-11-13

Similar Documents

Publication Publication Date Title
ECSP18040758A (es) Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos
CO2018011804A2 (es) Receptores quiméricos de flt3 y métodos de uso de los mismos
CL2018000457A1 (es) Anticuerpos anti-mesotelina completamente humanos y células con efecto inmune dirigido a la mesotelina
BR112016017806A2 (pt) células para imunoterapia engenheiradas para direcionamento de antígeno presente em ambas as células imunes e células patológicas
BR112017025564A2 (pt) anticorpos anti-ctla-4 e métodos de uso dos mesmos
AR095774A1 (es) Anticuerpos anti-il-4 y anticuerpos biespecíficos y sus usos
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
AR110645A1 (es) Anticuerpos anti-hla-g y uso de los mismos
DK3444334T3 (da) Fremgangsmåde til inducering af CD8+ T-celler
BR112019012343A2 (pt) anticorpos il-11ra
BR112017009806A2 (pt) sistema e método para gerar informações de nível de estresse e de nível de resiliência de estresse para um indivíduo
DK3253865T3 (da) Fremgangsmåder til forbedring af virkningen af terapeutiske immunceller
BR112017011932A2 (pt) ?anticorpos direcionados a receptor acoplado a proteína g e métodos de uso?
MX2018002293A (es) Sistemas y métodos para las llamadas variantes de alta precisión.
DK3693384T3 (da) Fremgangsmåde til at generere T-celler med kompatibilitet for allogen transplantation
AR101845A1 (es) Anticuerpos anti-her2 e inmunoconjugados
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
DK3926051T3 (da) Fremgangsmåder til høst af pattedyrecellekulturer
DK3157268T3 (da) Høreanordning og høresystem, der er konfigureret til at lokalisere en lydkilde
BR112017006520A2 (pt) métodos de tratamento do lúpus eritematoso sistêmico usando um anticorpo de domínio direcionado contra cd28
MX2018013727A (es) Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.
BR112018000847A2 (pt) biomassa de thraustochytridas rica em proteína, método de cultura, e usos
BR112017004202A2 (pt) composições para intensificar respostas imunes e seus usos
BR112017004444A2 (pt) novos anticorpos anti-mfi2 e métodos de uso
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2676 DE 19-04-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.